Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Drug Development Research|January 5, 2026
Protective Effects of Herbacetin in Experimental Colitis: Targeting NF-κB and NLRP3 PathwaysYousra Bseiso, Badriyah S Alotaibi, Alaa A A Aljabali, et al.
Current Reviews in Clinical and Experimental Pharmacology|September 5, 2025
MicroRNAs as Biomarkers and Therapeutic Targets in Treatment-Resistant Depression: Unveiling Diagnostic and Treatment PathwaysAlaa A A Aljabali, Almuthanna Alkaraki, Omar Gammoh, et al.
International Journal of Psychiatry in Medicine|August 6, 2024
PTSD symptoms among patients with multiple sclerosis in Jordan during October 7th Gaza war outbreakOmar Gammoh, Esam Qnais, Hanan Abu Alshaikh, et al.
International Journal of Molecular Sciences|March 29, 2023
The Emerging Importance of Cirsimaritin in Type 2 Diabetes TreatmentAbdelrahim Alqudah, Rabaa Y Athamneh, Esam Qnais, et al.
Behavioural Pharmacology|March 6, 2026
Evaluation of scopoletin as a potential therapeutic agent in fibromyalgia: evidence from a reserpine-induced mouse modelYousra Bseiso, Badriyah S Alotaibi, Alaa A A Aljabali, et al.
F1000Research|July 18, 2022
Knowledge and practice of community pharmacists towards SGLT2 inhibitorsAbdelrahim Alqudah, Muna Oqal, Ahmad Al-Samdi, et al.
Drug Development and Industrial Pharmacy|October 9, 2025
Cathepsin C: a critical mediator between immune response and cardiovascular disease - therapeutic implications of enzyme inhibitionAlaa A A Aljabali, Mohammad A Obeid, Omar Gammoh, et al.
The American Journal of the Medical Sciences|June 15, 2025
Therapeutic efficacy of scopoletin on oxidative stress and cardiac dysfunction in streptozotocin-induced diabetic ratsAbdelrahim Alqudah, Esam Qnais, Omar Gammoh, et al.
Expert Opinion on Biological Therapy|December 6, 2025
Natural killer cell therapies in cancer: innovations, challenges, and future directionsAlaa A A Aljabali, Omar Gammoh, Esam Qnais, et al.
International Journal of Molecular Sciences|February 24, 2024
Exploring the Roles of Vitamins C and D and Etifoxine in Combination with Citalopram in Depression/Anxiety Model: A Focus on ICAM-1, SIRT1 and Nitric OxideOmar Gammoh, Aseel Ibrahim, Ala Yehya, et al.
Pageof 9